Clinical Trials Directory

Trials / Unknown

UnknownNCT05061641

Prediction and Prevention of Twin Premature Birth 2021

Study on the Prediction and Prevention of Twin Premature Birth

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Caixia Liu · Academic / Other
Sex
Female
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

Research Objectives: 1. Establish a prediction and scoring system for twin premature birth. 2. To investigate the curative effect of 200mg,400mg and 600mg of vaginal progesterone in the prevention of twin premature birth. 3. To investigate the effect of stress cervical ligation in preventing premature delivery of twins. 4. The optimal dose of atosiban for the treatment of twin premature birth. 5. The influence of delivery mode on twin premature infants under 32 weeks.

Detailed description

Research Objectives: 1. Establish a prediction and scoring system for twin premature birth. 2. To investigate the curative effect of 200mg,400mg and 600mg of vaginal progesterone in the prevention of twin premature birth. 3. To investigate the effect of stress cervical ligation in preventing premature delivery of twins. 4. The optimal dose of atosiban for the treatment of twin premature birth. 5. The influence of delivery mode on twin premature infants under 32 weeks. It has now entered the second phase: clinical data collection

Conditions

Interventions

TypeNameDescription
DRUGProgesteroneThe delivery outcomes of the three groups were compared, including the rate of premature delivery (\<37 weeks of gestation), the rate of early premature delivery (\<32 weeks of gestation), and the need for anti-tocolysis treatment. Rates of premature rupture of membranes (\<37 weeks), neonatal perinatal mortality and morbidity.

Timeline

Start date
2021-05-01
Primary completion
2022-06-01
Completion
2022-06-01
First posted
2021-09-29
Last updated
2021-09-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05061641. Inclusion in this directory is not an endorsement.